« Previous
Next »
The Journal of Thoracic and Cardiovascular Surgery
Volume 135, Issue 6
, Pages 1237-1246
, June 2008
A novel bioengineered small-caliber vascular graft incorporating heparin and sirolimus: Excellent 6-month patency
References
- Use of both internal thoracic arteries in diabetic patients increases deep sternal wound infection. Ann Thorac Surg. 2007;83:1002–1006
- . The future of saphenous vein as a coronary artery bypass conduit. Eur Heart J. 1989;10:273–280
- . Coronary bypass surgery with internal-thoracic-artery grafts—effects on survival over a 15-year period. N Engl J Med. 1996;334:216–219
- Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med. 1986;314:1–6
- . Endothelial healing in vein grafts: proliferative burst unimpaired by genetic therapy of neointimal disease. Circulation. 2002;105:1686–1692
- Novel bioengineered small caliber vascular graft with excellent one-month patency. Ann Thorac Surg. 2006;83:517–525
- Improvement of patency rate in heparin-coated small synthetic vascular grafts. Circulation. 1998;98(19 Suppl):II319–II323
- . Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model. J Vasc Surg. 2004;39:1322–1328
- . Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res. 1995;76:412–417
- Neointimal formation after balloon-induced vascular injury in Yucatan minipigs is reduced by oral rapamycin. J Cardiovasc Pharmacol. 1999;33:829–835
- Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation. 1999;99:2164–2170
- Randomized study with the sirolimus-coated bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773–1780
- . Factors affecting the patency of small-caliber prostheses: observations in a suitable canine model. J Vasc Surg. 1991;14:441–448
- . Why small caliber vascular grafts fail: a review of clinical and experimental experience and the significance of the interaction of blood at the interface. J Surg Res. 1986;41:1–15
- . Superior late patency of small-diameter Dacron grafts seeded with omental microvascular cells: an experimental study. Ann Thorac Surg. 1994;58:677–683
- . Clinical experience with autologous endothelial cell-seeded polytetrafluoroethylene coronary artery bypass grafts. J Thorac Cardiovasc Surg. 2000;120:134–141
- Reduction of non-endothelial cell contamination of microvascular endothelial cell seeded grafts decreases thrombogenicity and intimal hyperplasia. Eur J Vasc Endovasc Surg. 2002;23:404–412
- . Endothelial cell attachment to the gamma irradiated small diameter polyurethane vascular grafts. Biomed Mater Eng. 2006;16:397–404
- . Modern Vascular Grafts. New York: McGraw-Hill, Inc; 1987;326
- . Development and evaluation of a novel decellularized vascular xenograft. Med Eng Phys. 2002;24:173–183
- . Arterial regeneration over absorbable prostheses. Arch Surg. 1982;117:1425–1431
Research supported by the NIST Advanced Technology program (Award 70NANB1H3032). Russell Kronengold and Scott Goldman report equity ownership in and are employees of Kensey Nash Corporation.
Presented at the American Association of Thoracic Surgery 87th Scientific Sessions, Washington DC, May, 2007.
PII: S0022-5223(07)01998-8
doi: 10.1016/j.jtcvs.2007.09.077
© 2008 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Thoracic and Cardiovascular Surgery
Volume 135, Issue 6
, Pages 1237-1246
, June 2008
